Gynecology and Obstetrics, University Hospitals KU Leuven, Leuven, Belgium
Development and Regeneration, KU Leuven, Leuven, Belgium.
Int J Gynecol Cancer. 2021 Jul;31(7):961-982. doi: 10.1136/ijgc-2021-002565. Epub 2021 Jun 10.
The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endoscopy (ESGE) jointly developed clinically relevant and evidence-based statements on the pre-operative diagnosis of ovarian tumors, including imaging techniques, biomarkers, and prediction models. ESGO/ISUOG/IOTA/ESGE nominated a multidisciplinary international group, including expert practising clinicians and researchers who have demonstrated leadership and expertise in the pre-operative diagnosis of ovarian tumors and management of patients with ovarian cancer (19 experts across Europe). A patient representative was also included in the group. To ensure that the statements were evidence-based, the current literature was reviewed and critically appraised. Preliminary statements were drafted based on the review of the relevant literature. During a conference call, the whole group discussed each preliminary statement and a first round of voting was carried out. Statements were removed when a consensus among group members was not obtained. The voters had the opportunity to provide comments/suggestions with their votes. The statements were then revised accordingly. Another round of voting was carried out according to the same rules to allow the whole group to evaluate the revised version of the statements. The group achieved consensus on 18 statements. This Consensus Statement presents these ESGO/ISUOG/IOTA/ESGE statements on the pre-operative diagnosis of ovarian tumors and the assessment of carcinomatosis, together with a summary of the evidence supporting each statement.
欧洲妇科肿瘤学会 (ESGO)、国际妇产科超声学会 (ISUOG)、国际卵巢肿瘤分析 (IOTA) 小组以及欧洲妇科内镜学会 (ESGE) 联合制定了关于卵巢肿瘤术前诊断的临床相关和基于证据的声明，包括影像学技术、生物标志物和预测模型。ESGO/ISUOG/IOTA/ESGE 提名了一个多学科的国际小组，包括在卵巢肿瘤术前诊断和卵巢癌患者管理方面具有领导力和专业知识的专家临床医生和研究人员（欧洲的 19 名专家）。该小组还包括一名患者代表。为确保声明基于证据，对当前文献进行了审查和批判性评价。根据对相关文献的审查，起草了初步声明。在一次电话会议上，全体小组成员讨论了每个初步声明，并进行了第一轮投票。当小组成员之间没有达成共识时，就会删除相关声明。投票人有机会在投票时提供意见/建议。然后根据这些意见/建议相应地修改声明。根据相同的规则进行了另一轮投票，以便全体小组成员评估声明的修订版本。该小组就 18 项声明达成了共识。本共识声明介绍了这些关于卵巢肿瘤术前诊断和癌转移评估的 ESGO/ISUOG/IOTA/ESGE 声明，并总结了每项声明所依据的证据。
